C-type lectin domain family 3 member B
CLEC3BproteinCLEC3B release from plaques or endothelium during ACS reflects acute vascular inflammation and plaque destabilization.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleDifferentially released during acute coronary syndrome; plaque destabilization marker.
Also acts inEndothelial activation/erosion
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000163815
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease.Frontiers in cardiovascular medicine · 2020 · PMID 32671099 · doi